Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDIFAST INCMED · Entity 6587 | Director | May 26, 2026 | May 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDIFAST INC
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,419 |
Ending reported balance
After 2026-05-26 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-26 · Grant · Acquired 11,680 · Balance 11,680 F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. Row 2 · 2026-05-26 · Grant · Acquired 6,739 · Balance 18,419 F2: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.
F2: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 23:34 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 6,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-038983 · wk-form4_1780011255.xml · nonDerivative · entry 2 Rose Jeffrey Matthew · CIK 0002137123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,419 F2 · shares: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. Read SEC document |
| May 26, 2026 Filed May 28, 2026 23:34 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 11,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-038983 · wk-form4_1780011255.xml · nonDerivative · entry 1 Rose Jeffrey Matthew · CIK 0002137123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,680 F1 · shares: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.